Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This was a placebo-controlled, double-blind, randomized trial designed with the aim of establishing whether curcumin influenced the duration of treatment interruption and rate of prostatic specific antigen(PSA) progression, compared with placebo among men with prostate cancer receiving intermittent androgen deprivation therapy.
Epistemonikos ID: 3668b63497d9a2b7c9da2abdd13286020c32388b
First added on: May 20, 2024